Document Type

Article

Publication Date

January 2017

Abstract

This paper finds that physicians and pharmaceutical companies working as entrepreneurial actors were able to better serve patients by finding effective alternative uses of three drugs. I examine off-label drug prescription within an entrepreneurial framework by examining the development processes of aspirin, Viagra, and minoxidil. In each case, the medical community reached research and treatment conclusions quicker than the FDA did. These examples provide counterevidence to the view that off-label prescription is reckless and requires additional governmental oversight due to a lack of sufficient testing

Comments

This article originally appeared in Journal of Private Enterprise, 32, 3, 2017. This work can also be found online at this link

Included in

Economics Commons

Share

COinS